Renal disease and hypertension in non-insulin-dependent diabetes mellitus

Kidney International

Volumn 55, Issue 1, 1999, Pages 1-28

  Ismail, Nuhad ^a   Becker, Bryan ^b   Strzelczyk, Piotr ^b   Ritz, Eberhard ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

ACE gene polymorphism; Albuminuria; Calcium channel blockers; Diabetic nephropathy; Hyperglycemia; Hyperlipidemia; Hypertension; Microalbuminuria; Urinar y albumin excretion

Indexed keywords

ALBUMIN;

DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GLOMERULUS FILTRATION; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0032956686     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00232.x     Document Type: Article

References (304)

1. The United States Renal Data System: USRDS Annual Data Report. Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995
2. Suzuki Y, Arakawa M: The treatment of the uraemic diabetic. Are we doing enough? A view from Japan. Fumitake Gejyo Collaborate Study Group. Nephrol Dial Transplant 10(Suppl 7):47-55, 1995
3. Raine AE: The rising tide of diabetic nephropathy: The warning before the flood? Nephrol Dial Transplant 10:460-461, 1995
4. Lippert J, Ritz E, Schwarzbeck A, Schneider P: The rising tide of endstage renal failure from diabetic nephropathy type II: An epidemiological analysis. Nephrol Dial Transplant 10:462-467, 1995
5. National Diabetes Data Group: Diabetes in America (2nd ed). Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468, 1995
6. Port FK: Worldwide demographics and future trends in end-stage renal disease. Kidney Int 41:S4-S7, 1993
7. Pirson Y: The diabetic patient with ESRD: How to select the modality of renal replacement. Nephrol Dial Transplant 11:1511-1513, 1996
8. Canadian Organ Replacement Register: 1992 Annual Report. Don Mills, Canadian Institute of Health Information, March, 1994
9. Australia and New Zealand Dialysis and Transplant Registry: Australia and New Zealand Data Report. Adelaide, South Australia, 1995
10. Valderrabano F, Jones EH, Mallick NP: Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 10(Suppl 5):1-25, 1995
11. Luft R, Wajngot A, Efendic S: On the pathogenesis of maturity-onset diabetes. Diabetes Care 4:58-63, 1981
12. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
13. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM, Bennett PH: Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31:730-767, 1988
14. Disney APS: Sixteenth Report of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). Woodville, South Australia, The Queen Elizabeth Hospital, 1993
15. Atalano C, Postorino M, Kelly PJ, Fabrizi F, Enia G, Goodship TH, Fulcher GR, Maggiore Q: Diabetes mellitus and renal replacement therapy in Italy: Prevalence, main characteristics and complications. Nephrol Dial Transplant 5:788-796, 1990
16. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167-194, 1996
17. Michaelis D, Jutzi E: Epidemiologie des diabetes mellitus in der Bevolkerung der ehemaligen DDR: Altersund geschlechtsspezifische Inzidenz and Pracalenztrends im Zeitraum 1960-1987. Z Klin Med 46:59-63, 1991
18. Diamond JM: Human evolution: Diabetes running wild. Nature 357:362-363, 1992
19. Panzram G, Marx M, Frommhold E, Darthel R: Untersuchungen uber Sterbealter, erlebte Diabetesdauer und Todesursachen unter den Verstorbenen einer geschlossenen Diabetes population. Wien Klin Wochenschr 89:147-150, 1997
20. Hasslacher C, Borgholte G, Panradl U, Wahl P: Verbessete Prognose von Typ-I und Typ-II Diabetikem mit Nephropathie. Med Klin 85:643-646, 1990
21. Friedman EA: Diabetic nephropathy in blacks. Transplant Proc 25:2431-2432, 1993
22. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ: The excess incidence of diabetic end-stage renal disease among blacks: A population-based study of potential explanatory factors. JAMA 268:3079-3084, 1992
23. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M: Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol 127:135-144, 1988
24. Newman JM, Marfin AA, Eggers PW, Helgerson SD: End stage renal disease among Native Americans, 1983-86. Am J Public Health 80:318-319, 1990
25. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure: Less one, more other? Am J Hypertens 1:335-347, 1988
26. Schmidt K, Pesce C, Liu Q, Nelson RG, Bennett PH, Karnitschnig H, Striker LJ, Striker GE: Large glomerular size in Pima Indians: Lack of change with diabetic nephropathy. J Am Soc Nephrol 3:229-235, 1992
27. Raine AE: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 36:1099-1104, 1993
28. Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu PC, O'Fallon WM, Palumbo PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
29. US Department of Health and Human Services, Public Health Service Centers for Disease Control: End-stage renal disease diabetes surveillance. Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, Atlanta, Annual Report, 1990, pp 33-40
30. Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus: The case of mainland France and of overseas French territories. Diabetologia 36:1109-1112, 1993
31. Ritz E, Keller CK, Bergis KH, Siebels M: Atteinte renale au cours du diabete de type II, in Actualite Nephrologique Jean Hamburger-Hopital Necker, edited by Grünfeld JP, Paris, Flammarion Medicine-Sciences, 1994, p 129
32. Zmirou D, Benhamou PY, Cordonnier D, Borgel F, Balducci F, Papoz L, Halimi S: Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study). Nephrol Dial Transplant 7:1092-1097, 1992
33. Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease: With emphasis on the stage of incipient diabetic nephropathy. Diabetes 32(Suppl 2):64-78, 1983
34. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978
35. Myers BD, Nelson RG, Williams GW, Bennett PH, Hardy SA, Berg RL, Loon N, Knowler WC, Mitch WE: Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 8:524-530, 1991
36. Hannedouche TP, Delgado AG, Gnionsahe DA, Bottard C, Lacour B, Grunfeld JP: Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int 37:1126-1133, 1990
37. Schmitz A, Hansen HH, Christensen T: Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 32:434-439, 1989
38. Nowack R, Raum E, Blum W, Ritz E: Renal hemodynamics in recent-onset type II diabetes. Am J Kidney Dis 20:342-347, 1992
39. Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR: Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 41:829-855, 1992
40. Palmisano JJ, Lebovitz HE: Renal function in black Americans with type II diabetes. J Diabetes Complications 3:40-44, 1989
41. DeCosmo S, Earle K, Morocutti A, Walker J, Ruggenenti P, Remuzzi G, Viverti GC: Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: Inhibition by acetylsalicylic acid infusion. Diabetologia 36:622-627, 1993
42. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving HH: Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21:683-688, 1982
43. Keller CK, Bergis KH, Fliser D, Ritz E: Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 7:2627-2635, 1996
44. Nelson RG, Knowler WC, McCance DR, Sievers ML, Pettitt DJ, Charles MA, Hanson RL, Liu QZ, Bennett PH: Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 36:1087-1093, 1993
45. Deckert T, Kofoed-Enevoldsen A, Vidal P, Norgaard K, Andearsen HB, Feldt-Rasmussen B: Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36:244-251, 1993
46. Oken DE, Kirschbaum BB, Landwehr DM: Micropuncture studies of the mechanisms of normal and pathologic albuminuria. Contrib Nephrol 24:1-7, 1981
47. Wahl P, Deppermann D, Hasslacher C: Biochemistry of glomerular basement membrane of the normal and diabetic human. Kidney Int 21:744-749, 1982
48. Tamsma JT, Van DB, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
49. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
50. Wiseman MJ, Saunders AJ, Keen H, Viverti G: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312:617-621, 1985
51. Schmitz A, Gundersen HJ, Osterby R: Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus: Lack of glomerular hypertrophy. Diabetes 37:38-43, 1988
52. Schmitz A, Nyengaard JR, Bendtsen TF: Glomerular volume in type 2 (noninsulin-dependent) diabetes estimated by a direct and unbiased stereologic method. Lab Invest 62:108-113, 1990
53. Schmitz A, Christensen T, Taagehoej JF: Glomerular filtration rate and kidney volume in normoalbuminuric non-insulin-dependent diabetics: Lack of glomerular hyperfiltration and renal hypertrophy in uncomplicated NIDDM. Scand J Clin Lab Invest 49:103-108, 1989
54. Inomata S: Renal hypertrophy as a prognostic index for the progression of diabetic renal disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications 7:28-33, 1993
55. Seymour AE: Glomerular disease in whites versus Australian aboriginals: 'Last of a race in ruin.' Nephrol Dial Transplant 10:769-770, 1995
56. Pagtalunan ME, Miller PL, Nelson RG, Myers BD, Coplon N, Meyer TW: Glomerular structure in Pima Indians with type II diabetes mellitus. (abstract) J Am Soc Nephrol 5:381, 1994
57. Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064-1070, 1993
58. Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Nishi S, Suzuki Y, Ogino S, Maruyama Y, Kouda Y: An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 41:749-757, 1992
59. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39: 1569-1576, 1996
60. Mogensen CE, Christensen CK: Blood pressure changes and renal function in incipient and overt diabetic nephropathy. Hypertension 7:1164-1173, 1985
61. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989
62. Osterby R, Parving HH, Hommel E, Jorgensen HE, Lokkegaard H: Glomerular structure and function in diabetic nephropathy: Early to advanced stages. Diabetes 39:1057-1063, 1990
63. Bilous RW, Mauer SM, Sutherland DE, Steffes MW: Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 38:1142-1147, 1989
64. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 320:966-970, 1989
65. Osterby R: Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: Causes, consequences, and prevention. Diabetologia 35:803-812, 1992
66. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE: Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25:107-112, 1995
67. Haffner SM, Gonzales C, Valdez RA, Mykkanen L, Hazuda HP, Mitchell BD, Monterrosa A, Stern MP: Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 36:1002-1006, 1993
68. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC: Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 32:870-876, 1989
69. Standl E, Stiegler H: Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. Diabetologia 36:1017-1020, 1993
70. Anonymous: UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hvperglycaemia and hypertriglyceridaemia. Diabetologia 36:1021-1029, 1993
71. Anonymous: UK Prospective Diabetes Study (UKPDS). IX. Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 36:835-842, 1993
72. Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin- dependent) diabetic patients. Diabetologia 34:655-661, 1991
73. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
74. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
75. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673-689, 1987
76. Schmitz A, Vaeth M, Mogensen CE: Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologica 37:1251-1258, 1994
77. Viberti G, Mogensen CE, Group LC, Pauls JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 271:275-279, 1994
78. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T: The predictive value of microalbuminuria in IDDM: A five-year follow-up study. Diabetes Care 17:120-125, 1994
79. Jarrett RJ, Viverti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabetes Med 1:17-19, 1984
80. Schmitz A, Vaeth M: Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetes Med 5:126-134, 1988
81. Uusitupa M, Siitonen O, Aro A, Pyorala K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28:22-27, 1985
82. Nielsen FS, Rossing P, Bang L, Smidt UM, Svendsen TL, Gall MA, Parving H-H: Endothelial dysfunction in NIDDM patients with and without nephropathy. (abstract) J Am Soc Nephrol 5:380, 1994
83. Knobl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, Muller M: Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050, 1993
84. Araki S, Kikkawa R, Naneda M, Koyo D, Togawa M, Mao LP, Shigeta Y: Microalbuminuria cannot predict cardiovascular death in Japanese subjects with NIDDM, in Fourth International Symposium on Hypertension Associated with Diabetes Mellitus, Otsu, Japan, 1994
85. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Liebow IM, Howard BV, Bennett PH: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987-995, 1990
86. Haneda M, Kikkawar R, Togawa M, Koyad D, Kajiwara N, Uzu T, Shigeta Y: High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus. J Diabetes Complications 6:181-185, 1992
87. Shinoda T, Ishihara M, Kurimoto F, Aizawa T, Hiramatsu K, Shirota T, Takasu N, Yamada T: Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin-dependent diabetes mellitus. Clin Nephrol 34:202-207, 1990
88. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, Den OG: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
89. Murakami T, Komiyama Y, Egawa H, Murata K: Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes 42:233-238, 1993
90. Luetscher JA, Kraemer FB: Microalbuminuria and increased plasma prorenin: Prevalence in diabetics followed up for four years. Arch Intern Med 148:937-941, 1988
91. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 45:216-222, 1996
92. Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, Jerums G: Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 43:649-655, 1994
93. Pughja A, Medina R, Ramirez M: Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 36: 1094-1098, 1993
94. Fabre J, Balant LP, Dayer PG, Vernet AT: The kidney in maturity onset diabetes mellitus. Kidney Int 21:730-738, 1982
95. Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS: Joslin's Diabetes Mellitus. Philadelphia, Lea and Febiger, 1985
96. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131, 1987
97. Geiss LS, Herman WH, Teutsch SM: Diabetes and renal mortality in the United States. Am J Public Health 75:1325-1326, 1985
98. Balodimos MC: Diabetic nephropathy, in Joslin's Diabetes Mellitus, edited by Marble A, White P, Bradley RF, Krall LP, Philadelphia, Lea and Febiger, 1971, p 526
99. Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH: Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 35:681-687, 1989
100. Knowler WC, Kunzelman CL: Population comparisons of the frequency of nephropathy, in The Kidney and Hypertension in Diabetes Mellitus, edited by Mogensen CE, Boston, Martinus Nijhoff Publishing, 1988, p 25
101. Hasslacher C, Ritz E, Wahl P, Michael C: Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 4:859-863, 1989
102. Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW: Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25:836-844, 1995
103. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: Effect of proteinuria on mortality in NIDDM. Diabetes 37:1499-1450, 1988
104. Humphreys P, McCarthy M, Tuomilehto J, Tuomilehto-Wolf E, Stratton I, Morgan R, Rees A, Owens D, Stengard J, Nissinen A: Chromosome 4q locus associated with insulin resistance in Pima Indians: Studies in three European NIDDM populations. Diabetes 43:800-804, 1994
105. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ: Chronic renal failure in non-insulin-dependent diabetes mellitus: A population-based study in Rochester, Minnesota. Ann Intern Med 111:788-796, 1989
106. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
107. Kussman MJ, Goldstein H, Gleason RE: The clinical course of diabetic nephropathy. JAMA 236:1861-1863, 1976
108. Tuttle KR, Stein JH, DeFronzo RA: The natural history of diabetic nephropathy. Semin Nephrol 10:184-193, 1990
109. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Dis Study Group. N Engl J Med 335:1636-1642, 1996
110. Ordonez JD, Hiatt RA: Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population. Nephron 51:524-529, 1989
111. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 9:1097-1110, 1994
112. Olivarius ND, Andreasen AH, Keiding N, Mogensen CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients: Cross-sectional data from the population-based study 'Diabetes Care in General Practice,' Denmark. Diabetologia 36:1007-1016, 1993
113. Gall MA, Nielsen FS, Smitz UM, Parving HH: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36:1071-1078, 1993
114. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P: Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1051-1056, 1993
115. Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121:912-918, 1994
116. Ohno T, Kato N, Shimizu M, Ishii C, Ito Y, Tomono S, Kawazu S, Murata K: Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension. Diabetes Res 22:115-121, 1989
117. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
118. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
119. Freedman BI, Tuttle AB, Spray BJ: Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 25:710-713, 1995
120. Burden AC, McNally PG, Feehally J, Walls J: Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med 9:641-645, 1992
121. Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, Knowler WC: Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 36:998-1001, 1993
122. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lack AB, Rudzki H, Schmidt S, Keller C, Ritz E: Nephropathy of type II diabetes: Evidence for hereditary factors. Kidney Int 51:1602-1607, 1997
123. Yoshida H, Kon V, Ichikawa I: Polymorphisms of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 50:732-744, 1996
124. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenbergstasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH: Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 96:759-766, 1995
125. Chowdhury TA, Kumar S, Barnett AH, Bain SC: Nephropathy in type 1 diabetes: The role of genetic factors. Diabet Med 12:1059-1067, 1995
126. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard Jm, Bara L, Ricard S: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
127. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
128. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
129. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
130. Tarnow L, Cambein F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
131. Schmidt S, Schone N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 47:1176-1181, 1995
132. Biolo HJG, Thijissen S, De Knijff P, Stehouwer CD, Kluft C: ACE and ANG gene polymorphism and diabetic nephropathy. (abstract) J Am Soc Nephrol 6:1037, 1995
133. Parving HH, Tarnow L, Rossing P: Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2509-2517, 1996
134. Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJUK: Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995
135. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39:97-102, 1996
136. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kudo H, Kawaguchi Y, Kon V, Matsusoka K, Ichikawa I, Sakai O: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664, 1996
137. Schmidt S, Strojek K, Grzeszczak W, Ganetn D, Ritz E: The M235T variant of the angiotensinogen gene and nephropathy in type 2 diabetes. J Am Soc Nephrol 6:104-107, 1995
138. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E: Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 12:427-429, 1997
139. Fogarty DG, Harron JC, Hughes AE, Doherty CC, Maxwell AP: The association of an angiotensinogen gene variant with diabetic nephropathy. (abstract) J Am Soc Nephrol 6:449, 1995
140. Pinkney JH, Foyle WJ, Denver AE, Mohamed-ali V, McKinlay S, Yudkin JS: The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 38:356-362, 1995
141. Rutherford PA, Thomas TH, Taylor R, Wilkinson R: Nephropathy and changes in sodium-lithium countertransport kinetics in type 2 (non-insulin-dependent) diabetes mellitus. J Hum Hypertens 8:29-35, 1994
142. + countertransport in non-insulin-dependent diabetics with diabetic nephropathy. Kidney Int 39:135-140, 1991
143. Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I, Seino Y: Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 17:977-982, 1994
144. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
145. Beuckelmann D, Erdmann E: Exogenous factors influencing the human erythrocyte sodium-lithium countertransport system. Eur J Clin Invest 14:392-397, 1984
146. Pietruck F, Spleiter S, Dual A, Philipp T, Derwahl M, Schatz H, Siffert W: Enhanced G protein activation in IDDM patients with diabetic nephropathy. Diabetologia 41:94-100, 1998
147. Berkman J, Rifkin H: Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): Report of a case. Metabolism 22:715-722, 1973
148. Steffes MW, Vernier RL, Brown DM, Basgen JM, Mauer SM: Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation. Diabetologia 23:347-353, 1982
149. Viberti GC, Earle K: Predisposition to essential hypertension and the development of diabetic nephropathy. J Am Soc Nephrol 3(Suppl 1):S27-S33, 1992
150. Maranon G: Uber hypertonie und zuckerkranheit. Zentralbl Innere Med 43:169-181, 1992
151. Stern MP: Diabetes and cardiovascular disease: The 'common soil' hypothesis. Diabetes 44:369-374, 1995
152. McCance DR, Nelson RG, Jacobsson LTH, Bishop DT, Knowler WC: Nephropathy in diabetic parents: A risk factor for diabetes in offspring. (abstract) Diabetes 42(Suppl 1):135A, 1993
153. Hasslacher C, Wolfrum M, Stech G, Wahl P, Ritz E: Diabetic nephropathy in type II diabetes: Effect of metabolic control and blood pressure on its development and course. Deutsche Med Wochenschrift 112:1445-1449, 1987
154. Pell S, D'Alonzo CA: Some aspects of hypertension in diabetes mellitus. JAMA 202:104-110, 1967
155. Ritz E, Hasslacher C, Mann JF, Guo JZ: Hypertension and vascular disease as complications in diabetes, in Hypertension-Pathophysiology, Diagnosis and Management, edited by Laragh JH, Brennner BM, New York, Raven Press, 1990, p 1705
156. Reisin E, Messerli FH: Obesity-related hypertension: Mechanisms, cardiovascular risks, and heredity. Curr Opin Nephrol Hypertens 4:67-71, 1995
157. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, Bennett PH: Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 26:127-133, 1984
158. Nosadini R, Solina A, Velussi M, Muollo B, Frigato F, Sambataro M, Cipollina MR, De RF, Brocco E, Crepaldi G: Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 43:491-499, 1994
159. Niskanen L, Laakso M: Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 42:1541-1545, 1993
160. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557, 1994
161. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
162. Nosadini R, Sambataro M, Thomaseth K, Pacini G, Cipollina MR, Brocco E, Solini A, Carraro A, Velussi M, Frigato F: Role of hyperglycemia and insulin resistance in determining sodium retention in non-insulin-dependent diabetes. Kidney Int 44:139-146, 1993
163. Lee ET, Lee VS, Lu M, Lee JS, Russell D, Yeh J: Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study. Diabetes 43:572-579, 1994
164. Nelson RG, Knowler WC, Pettitt DJ, Hanson RL, Bennett PH: Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 18:182-187, 1995
165. Goldschmid MG, Domin WS, Ziemer DC, Gallina DL, Phillips LS: Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. Diabetes Care 18:955-961, 1995
166. Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH: Incipient and overt diabetic nephropathy in African Americans with NIDDM. Diabetes Care 17:297-304, 1994
167. Anonymous: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986, 1993
168. Chase HP, Garg SK, Marshall G, Berg CL, Harros S, Jackson WE, Hamman RE: Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265:614-617, 1991
169. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
170. Mimran A, Ribstein J, Ducailar G, Halimi JM: Albuminuria in normals and essential hypertension. J Diabetes Compl 8:150-156, 1994
171. Paterson AM, Mancia G, Fitzgerald GA: Proceedings of the symposium on smoking: A risk factor for cardiovascular disease. Am Heart J 115(Suppt 2):S240-S294, 1988
172. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219-226, 1989
173. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375-380, 1982
174. Greene DA, Lattimer SA, Sima AA: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
175. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
176. Kanwar YS, Rosenzweig LJ, Linker A, Jakubowski ML: Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence. Proc Natl Acad Sci USA 80:2272-2277, 1983
177. Larkins RG, Dunlop ME: The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35:499-504, 1992
178. Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti G, Osterby R: Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 41:741-748, 1992
179. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J 4:2850-2859, 1990
180. Vora JP, Zimsen SM, Houghton DC, Anderson S: Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J Am Soc Nephrol 7:113-117, 1996
181. Lavaud S, Michel O, Sassy-Prigent C, Heudes D, Bazin R, Bariety J, Chevalier J: Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 7:2604-2615, 1996
182. Kasiske BL, O'Donnell L MP, Keane WF: The obese Zucker rat model of glomerular injury in type II diabetes. J Diabet Compl 1:26-29, 1987
183. O'Donnell MP, Kasiske BL, Cleary MP, Keane WF: Effects of genetic obesity on renal structure and function in the Zucker rat. II Micropuncture studies. J Lab Clin Med 106:605-610, 1985
184. Ikeda H, Shino A, Matsuo T, Iwatsuka H, Suzuoki Z: A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes 30: 1045-1050, 1981
185. Zeigler DW, Patel KP: Reduced renal responses to an acute saline load in obese Zucker rats. Am J Physiol 261:R712-R718, 1991
186. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
187. Sasaki T, Kurata H, Nomura K, Utsunomi YAK, Ikeda Y: Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus. Jpn J Med 29:156-163, 1990
188. Deckert T, Parving H-H, Christiansen JS, Oxemboll B, Svendsen PA, Telmer S, Christy M, Lauritzen T, Thomsen OF, Kreiner S, Andersen JR, Binder C, Nerup J: Diabetic nephropathy: A clinical and morphometric study, in Advances in Diabetes Epidemiology, edited by Eschwege E, Heidelberg, Elsevier Biomedical Press B.V., 1982, p 235
189. Watkins PJ: Diabetic nephropathy: Prevalence, complications and treatment. Diabet Med 2:7-12, 1985
190. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762, 1992
191. Marshall SM, Alberti KG: Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 70:61-71, 1989
192. Schwartz MM, Lewis EJ, Leonard-Martin TC: Renal clinicopathology of type II diabetes mellitus (DM). (abstract) J Am Soc Nephrol 7:1364, 1996
193. Gambara V, Mecca G, Remuzzi G, Bertani T: Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 3:1458-1466, 1993
194. Lipkin GW, Yeates C, Howie A, Michael J, Adu D, Richards NT: More than one third of type 2 diabetes with renal disease do not have diabetic nephropathy: A prospective study. (abstract) J Am Soc Nephrol 5:379, 1994
195. Amoah E, Glickman JL, Malchoff CD, Sturgill BC, Kaiser DL, Bolton WK: Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol 8:204-211, 1988
196. Suzuki Y, Ueno M, Hayashi H, Nishi S, Satou H, Karasawa R, Inn H, Suzuki S, Maruyama Y, Arakawa M: A light microscopic study of glomerulosclerosis in Japanese patients with noninsulin-dependent diabetes mellitus: The relationship between clinical and histological features. Clin Nephrol 42:155-162, 1994
197. Waldherr R, Ilkenhans C, Ritz E: How frequent is glomerulonephritis in diabetes mellitus type II? Clin Nephrol 37:271-273, 1992
198. Pinel N, Fadel B, Bilous RW, Corticelli P, Halimi S, Cordonnier DJ: Renal biopsies in 30 micro- and macroalbuminuric non-insulin-dependent (type 2) (NIDDM) patients: Heterogeneity of renal lesions, in Eighth Meeting of the European Diabetic Nephropathy Study Group, Heidelberg, Germany, 1995
199. O'Neill WMJ, Wallin JD, Walker PD: Hematuria and red cell casts in typical diabetic nephropathy. Am J Med 74:389-395, 1983
200. Kasinath BS, Mujais SK, Spargo BH, Katz AI: Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 75:613-617, 1983
201. Kaiser UB, Ethier JH, Kamel KS, Halperin ML: Persistent hyperkalemia in a patient with diabetes mellitus: A reversible defect in kaliuresis during bicarbonaturia. Clin Invest Med 15:187-193, 1992
202. Villoria JG, Macias Nunez JF, Miralles JM, DeCastro del Pozo S, Tabernero Romo JM: Hyporeninemic hypoaldosteronism in diabetic patients with chronic renal failure. Am J Nephrol 8:127-137, 1988
203. Antonipillai I, Nadler J, Vu EJ, Bughi S, Natarajan R, Horton R: A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease. J Clin Endocrinol Metab 81:1940-1945, 1996
204. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084, 1995.
205. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The Modification Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995
206. Lewis EJ, Hunsickler LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
207. Ritz E, Nowack R, Fliser D, Koch M, Tschope W: Type II diabetes mellitus: Is the renal risk adequately appreciated? Nephrol Dial Transplant 6:679-682, 1991
208. Weidmann P, Beretta-Piccoli C, Keusch G, Gluck Z, Mujagic M, Grimm M, Meier A, Ziegler WH: Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 67:779-784, 1979
209. Strojek K, Grzeszczak W, Lacka B, Gorska J, Keller CK, Ritz E: Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria. Diabetologia 38:1443-1448, 1995
210. Warram JH, Laffel LM, Valsania P, Christlieb AR, Krolewski AS: Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 151:1350-1356, 1991
211. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 276:1886-1892, 1996
212. Bjorck S: Clinical trials in overt diabetic nephropathy, in The Kidney and Hypertension in Diabetes Mellitus, edited by Mogensen CE, Boston, Dordrecht, London, Kluwer Academic Publishers, 1997
213. Heeg JE, de Jong PE, van der Hem GK, De Zeeuw D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36:272-279, 1989
214. Chan JC, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R: Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: One year analysis. BMJ 305:981-985, 1992
215. Bakris GL, Smith A: Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Ann Intern Med 125:201-204, 1996
216. Mulec H, Blohme G, Kullenberg K, Nyberg G, Bjorck S: Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 38: 216-220, 1995
217. Ellison DH: The physiologic basis of diuretic synergism: Its role in treating diuretic resistance. Ann Intern Med 114:886-894, 1991
218. Fliser D, Schroter M, Neubeck M, Ritz E: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 46:482-488, 1994
219. Ferder L, Daccordi H, Martello M, Panzalis M, Inserra F: Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients. Hypertension 19(Suppl 2):237-242, 1992
220. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
221. Weidmann P, Boehlen LM, de Courten M: Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 8:582-584, 1993
222. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 50:1641-1650, 1996
223. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
224. Lacourciere Y, Nadeau A, Poirier L, Tancrede G: Captopril or conventional therapy in hypertensive type II diabetics: Three-year analysis. Hypertension 21:786-794, 1993
225. Anonymous: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. BMJ 302:210-216, 1991
226. Gansevoort RT, Apperloo AJ, Heeg JE, de Jong PE, de Zeeuw D: The antiproteinuric effect of antihypertensive agents in diabetic nephropathy. Arch Intern Med 152:2137-2139, 1992
227. Lebovitz HE, Wiegmann TB, Cnaan A, Shahinf ARS, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 45(Suppl 45):S150-S155, 1994
228. Vuorinen-Markkola H, Yki-Jarvinen H: Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 44:85-89, 1995
229. Mosconi L, Ruggenenti P, Perna A, Mecca G, Remuzzi G: Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes. Kidney Int 49(Suppl 55):S91-S93, 1996
230. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945, 1996
231. Ritz E, Orth SR, Strzelczyk P: Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease. J Hypertens 15:S21-S26, 1997
232. Corradi L, Lusardi P, Pasotti C, Zoppi A, Preti P, Lazzari P, Fogari R: Effects of amlodipine vs. fosinoprol on microalbuminuria in elderly hypertensive patients with type II diabetes. (abstract) Am J Hypertens 9:152A, 1996
233. Bakris GL: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 112:707-708, 1990
234. CoCa A, Sobrino J, Modol J, Soler J, Minguez A, Plana J, DeLaSierra A: A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension. J Hum Hyperterns 10:837-841, 1996
235. Romero R, Salinas I, Lucas A, Teixido J, Audi L, Sanmarti A: Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Diabetes Res Clin Pract 17:191-198, 1992
236. Hermann LS, Scherstein B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A: Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations: A double-blind controlled study. Diabetes Care 17:1100-1109, 1994
237. Hemmelder MD, de Zeeuw D, de Jong P: Verapamil is not as effective as ACE inhibition in the reduction of non-diabetic proteinuria. (abstract) J Am Soc Nephrol 1344, 1996
238. Lejmert T, Lubrich-Birkner I, Dreyling K, Scholmeyer P: Effects of captopril and diltiazem on proteinuria: A crossover double-blind study. (abstract) J Am Soc Nephrol 1322, 1996
239. Stefanski A, Amann K, Ritz E: To prevent progression: ACE inhibitors, calcium antagonists or both? Nephrol Dial Transplant 10:151-153, 1995
240. Cruickshank JM: Coronary flow reserve and the J curve. BMJ 298:457-458, 1989
241. Fletcher AE, Bulpitt CJ: How far should blood pressure be lowered? N Engl J Med 326:251-254, 1992
242. Klahr S: Role of dietary protein and blood pressure in the progression of renal disease. (abstract) Kidney Int 49:1783, 1996
243. Zuanetti G, Maggioni AP, Keane WF, Ritz E: Nephrologists neglect administration of beta blockers to dialysed diabetic patients. Nephrol Dial Transplant 12:2497-2500, 1997
244. Koch M, Thomas B, Tschope W, Ritz E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 36:1113-1117, 1993
245. Barbosa J, Steffes MW, Sutherland DE, Connett JE, Rao KV, Mauer SM: Effect of glycemic control on early diabetic renal lesions: A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. JAMA 272:600-606, 1994
246. Wu MS, Yu CC, Yang CW, Wu CH, Haung JY, Hong JJ, Fan CC, Huang CC, Leu ML: Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 12:2105-2110, 1997
247. Kuusisto J, Mykkanen L, Pyorala K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
248. Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:136-145, 1996
249. Colwell JA: The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. Ann Intern Med 124:131-135, 1996
250. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
251. Henry RR, Genuth S: Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:175-177, 1996
252. Raal FJ, Kalk WJ, Lawson M, Esser JD, Buys R, Fourie L, Panz VR: Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: A 6-mo prospective study. Am J Clin Nutr 60:579-585, 1994
253. Dullaart RP, Beusekamp BJ, Van Meijer S, DJ, Sluiter WJ: Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 16:483-492, 1993
254. Jameel N, Pughja A, Mitchell BD, Stern MP: Dietary protein intake is not correlated with clinical proteinuria in NIDDM. Diabetes Care 15:178-183, 1992
255. Pomerleau J, Verdy M, Garrel DR, Nadeau MH: Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:829-834, 1993
256. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
257. Brodsky IG, Robbins DC, Hiser E, Fuller SP, Fillyaw M, Devlin JT: Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 75:351-357, 1992
258. Toeller M, Buyken A, Heitkamp G, Bramswig S, Mann J, Milne R, Gries FA, Keen H: Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia 40:1219-2326, 1997
259. Ritz E, Fliser D: Hypertension and vascular disease as complications of diabetes, in Hypertension: Pathophysiology, Diagnosis and Management, edited by Laragh JH, Brenner BM, New York, Raven Press, 1995
260. Groop PH: Lipidaemia and diabetic renal disease, in The Kidney and Hypertension in Diabetes Mellitus, edited by Mogensen CE, Boston, Dordrecht, London, Kluwer Academic Publishers, 1996
261. Niskanen L, Sarlund H, Laakso M: Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus. Metabolism 44:1099-1104, 1995
262. Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen MR: Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Nephron 45:974-979, 1996
263. Nikkila EA, Huttunen JK, Ehnholm C: Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus: Relationship to plasma triglyceride metabolism. Diabetes 26:11-21, 1997
264. Taskinen MR, Nikkila EA, Kuusi T, Harmo K: Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia 22:46-50, 1982
265. Nielsen FS, Voldsgaard AI, Gall MA, Rossing P, Hommel E, Andersen P, Dyerberg J, Parving HH: Apolipoprotein (a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 36:438-444, 1993
266. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, Deambrogio P, Pagano G: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 19:43-47, 1996
267. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF: Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86: 475-482, 1992
268. Kronenberg F, Utermann G, Dieplinger H: Lipoprotein(a) in renal disease. Am J Kidney Dis 27:1-25, 1996
269. Schernthaner G, Kostner GM, Dieplinger H, Prager R, Muhlhauser I: Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: Cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 49:277-293, 1983
270. Haffner SM, Morales PA, Stern MP, Gruber MK: Lp(a) concentrations in NIDDM. Diabetes 41:1267-1272, 1992
271. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane Collaborative Study. Nephron 31:103-110, 1982
272. Tschope W, Koch M, Thomas B, Ritz E: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis: Results of a prospective study. The German Study Group Diabetes Uremia. Nephron 64:354-358, 1993
273. Ravid M, Neumann L, Lishner M: Plasma lipids and the progression of nephropathy in diabetes mellitus lype II: Effect of ACE inhibitors. Kidney Int 47:907-910, 1995
274. Lehmann R, Vokac A, Niedermann K, Agosti K, Spinas GA: Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 38:1313-1319, 1995
275. Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D: Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia. Am J Med 96:69S-78S, 1994
276. Aronson D, Rayfield EJ: Diabetes and obesity, in Atherosclerosis and Coronary Artery Disease, edited by Fuster V, Ross R, Topol EJ, Philadelphia, Lippincott-Raven, 1996
277. Anonymous: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA, 269:3015-3023, 1993
278. Biesenbach G, Janko O, Stuby U, Zazgornik J: Myoglobinuric renal failure due to long-standing lovastatin therapy in a patient with pre-existing chronic renal insufficiency. Nephrol Dial Transplant 11:2059-2060, 1996
279. Wanner C: HMG-CoA reductase inhibitor treatment in renal insufficiency. Nephrol Dial Transplant 11:1951-1952, 1996
280. Siegel JE, Krolewski AS, Warram JH, Weinstein MC: Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 3(Suppl 4):S111-S119, 1992
281. Anonymous: Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation. Diabetes Care 17:1357-1361, 1994
282. Tiu SC, Lee SS, Cheng MW: Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care 16:616-620, 1993
283. Stein PP, Black HR: Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 14:425-448, 1991
284. Murray KM: Calcium-channel blockers for treatment of diabetic nephropathy. Clin Pharmacol 10:862-865, 1991
285. Rossing P, Hommel E, Smidt UM, Parving HH: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45(Suppl):S145-S149, 1994
286. DeRubertis FR, Craven PA: Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am J Kidney Dis 22:727-735, 1993
287. Leroith D, Werner H, Phillip M, Roberts CTJ: The role of insulin-like growth factors in diabetic kidney disease. Am J Kidney Dis 22:722-726, 1993
288. Ziyadeh FN, Sharma K: Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int 48(Suppl 51):S34-S36, 1995
289. Pfeilschifter J: Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy? Kidney Int 48(Suppl 51):S50-S60, 1995
290. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26-29, 1992
291. Han DC, Kim JH, Cha MK, Song KI, Hwang SD, Lee HB: Effect of HMG CoA reductase inhibition on TGF-beta 1 mRNA expression in diabetic rat glomeruli. Kidney Int 48(Suppl 51 ):S61-S65, 1995
292. Solini A, Vergnani L, Ricci F, Crepaldi G: Glycosaminoglycans delay the progression of nephropathy in NIDDM. Diabetes Care 20:819-823, 1997
293. O'Dea K: Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes 33:596-603, 1984
294. Eriksson KF, Lindgarde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: The 6-year Malmo feasibility study. Diabetologia 34:891-898, 1991
295. Klein R: Big country: The roots of American obesity. Mainichi Daily News 3:7, 1994
296. Friedman EA: How can the care of diabetic ESRD patients be improved? Semin Dial 4:13-14, 1991
297. Anonymous: Black-white disparities in health care. JAMA 263:2344-2346, 1990
298. Marrero DG: Current effectiveness of diabetes health care in the U.S. How far from the ideal? Diabetes Rev 2:292-309, 1994
299. Hiss RG, Anderson RM, Hess GE, Stepien CJ, Davis WK: Community diabetes care: A 10-year perspective. Diabetes Care 17:1124-1134, 1994
300. Gohdes D, Rith-Najarian S, Acton K, Shields R: Improving diabetes care in the primary health setting: The Indian Health Service experience. Ann Intern Med 124:149-152, 1996
301. Pommer W, Bressel F, Chen F, Molzahn M: There is room for improvement of preterminal care in diabetic patients with end-stage renal failure: The epidemiological evidence in Germany. Nephrol Dial Transplant 12:1318-1320, 1997
302. Berger M, Jorgens V, Flatten G: Health care for persons with non-insulin-dependent diabetes mellitus: The German experience. Ann Intern Med 124:153-155, 1996
303. Keen H: Management of non-insulin-dependent diabetes mellitus: The United Kingdom experience. Ann Intern Med 124:156-159, 1996
304. American Diabetes Association, National Kidney Foundation: Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 17:1357-1361, 1994